SecBot SecBot
144 ·Filed Jun 10, 2026

RTGN

RetinalGenix Technologies Inc.
NEUTRAL
Impact 4/10
Horizondays Processed4mo ago SEC0001493152-26-028062
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Form 144 is an advance notice of intent to sell; the actual sale may or may not occur. Monitor for subsequent Form 4 filings to confirm execution. The relatively large share count relative to a micro-cap company suggests potential near-term selling pressure.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
RTGN ▲ 0.00% at T+60d
NEUTRAL call 0.00% · α vs SPY -6.86% · entry $4.00 → $4.00
Entry = T+0 close
Jun 10, 2026
via day close
T+1d
0.00%
call 0.00% · α -1.70%
$4.00
settled 5mo ago
T+5d
0.00%
call 0.00% · α -2.14%
$4.00
settled 4mo ago
T+20d
0.00%
call 0.00% · α -3.89%
$4.00
settled 4mo ago
T+60d
0.00%
call 0.00% · α -6.86%
$4.00
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Steven Bayern, a shareholder reporting via Bayern Capital LLC, filed a Form 144 notice of intent to sell 181,900 common shares (~$727,600 at ~$4.00/share) on or after June 11, 2026. The shares come from an exercise of warrants acquired in September 2018. No other details on total holdings or market cap are available, but relative to a likely micro-cap OTC company, this is material.

Key Facts

  • Steven Bayern (shareholder) filed Form 144 to sell 181,900 common shares.
  • Estimated aggregate market value of shares to be sold: $727,600.
  • Shares were acquired via exercise of warrants on 09/01/2018.
  • Sale intended to commence on or after 06/11/2026 on the OTCQB.
  • Broker is Alpine Securities Corporation.
  • Issuer is RetinalGenix Technologies Inc., an OTC-traded medical instruments company.

Financial Impact

Proposed sale of ~$727,600 worth of common shares, based on the filing's estimated price of ~$4.00 per share.

dilutioninsider ownership

Risk Factors

  • Insider sale, if executed, could signal reduced conviction or simple liquidity need.
  • OTC-traded micro-cap stocks are illiquid; a block sale could depress price.
  • No context on total holdings — impact depends on proportionality of this sale to Bayern's remaining stake.

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001493152-26-028062
Document: 0001493152-26-028062-index.html0001493152-26-028062
Document: 0001493152-26-028062.txt0001493152-26-028062

US Market Status

Market Closed — Opens Thu (9h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 10, 2026